Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF) Freely available
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (10)
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Molenaar, E. T. H.
Right arrow Articles by Voskuyl, A. E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Molenaar, E. T. H.
Right arrow Articles by Voskuyl, A. E.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Rheumatology 2000; 39: 742-744
© 2000 British Society for Rheumatology

Levels of markers of bone resorption are moderately increased in patients with inactive rheumatoid arthritis

E. T. H. Molenaar, W. F. Lems1, B. A. C. Dijkmans1, M. H. M. T. de Koning2, R. J. van de Stadt2 and A. E. Voskuyl

Department of Rheumatology, University Hospital Vrije Universiteit, Amsterdam,
1 Department of Rheumatology, University Hospital Vrije Universiteit, Jan van Breemen Instituut, Slotervaart Ziekenhuis, Amsterdam and
2 Jan van Breemen Instituut, Amsterdam, The Netherlands

Objective. Clinical remission occurs in 10–20% of patients with rheumatoid arthritis (RA). However, it is questionable whether clinical remission corresponds to the complete absence of the inflammatory process. To answer this question we measured collagen degradation products (which are known to be increased in active disease) in patients with inactive RA and in healthy controls.

Patients and methods. The urinary levels of bone resorption markers (pyridinoline, deoxypyridinoline, N-terminal telopeptide and C-terminal telopeptide) were measured in 184 patients with inactive RA, as defined by the preliminary criteria of clinical remission of the American College of Rheumatology, and in 118 healthy individuals.

Results. After adjusting for age, concentrations of all four bone resorption markers were found to be significantly higher in patients with inactive RA than in healthy controls.

Conclusion. The urinary excretion of bone resorption markers is increased in patients classified as having inactive RA. These results suggest that the inflammatory process is not completely absent.

KEY WORDS: Bone resorption markers, Bone metabolism, Disease activity, Remission, Rheumatoid arthritis.

Correspondence to: E. T. H. Molenaar, Department of Rheumatology, University Hospital Vrije Universiteit, P. O. Box 7057, 1007 MB Amsterdam, The Netherlands.


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
The Journal of RheumatologyHome page
S. W. SYVERSEN, R. LANDEWE, D. van der HEIJDE, J. M. BATHON, M. BOERS, V. P. BYKERK, O. FITZGERALD, D. D. GLADMAN, P. GARNERO, P. GEUSENS, et al.
Testing of the OMERACT 8 Draft Validation Criteria for a Soluble Biomarker Reflecting Structural Damage in Rheumatoid Arthritis: A Systematic Literature Search on 5 Candidate Biomarkers
J Rheumatol, August 1, 2009; 36(8): 1769 - 1784.
[Abstract] [Full Text] [PDF]


Home page
Ann Rheum DisHome page
S A YOUNG-MIN, T E CAWSTON, and I D GRIFFITHS
Markers of joint destruction: principles, problems, and potential
Ann Rheum Dis, June 1, 2001; 60(6): 545a - 548.
[Full Text]



Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.